Dashboard
1
With ROE of 15.85%, it has a very attractive valuation with a 2.97 Price to Book Value
- Over the past year, while the stock has generated a return of -17.89%, its profits have risen by 20% ; the PEG ratio of the company is 0.9
- At the current price, the company has a high dividend yield of 5.3
Stock DNA
Pharmaceuticals & Biotechnology
CNY 30,620 Million (Large Cap)
19.00
NA
5.35%
-0.85
15.85%
2.97
Revenue and Profits:
Net Sales:
1,315 Million
(Quarterly Results - Jun 2025)
Net Profit:
393 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.21%
0%
-3.21%
6 Months
-14.09%
0%
-14.09%
1 Year
-18.21%
0%
-18.21%
2 Years
-6.38%
0%
-6.38%
3 Years
21.14%
0%
21.14%
4 Years
13.47%
0%
13.47%
5 Years
8.69%
0%
8.69%
Dong-E-E-Jiao Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
23.52%
EBIT Growth (5y)
32.48%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.77
Sales to Capital Employed (avg)
0.49
Tax Ratio
16.52%
Dividend Payout Ratio
99.84%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
36.60%
ROE (avg)
8.42%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.97
EV to EBIT
12.44
EV to EBITDA
11.43
EV to Capital Employed
13.82
EV to Sales
3.56
PEG Ratio
0.94
Dividend Yield
5.35%
ROCE (Latest)
111.04%
ROE (Latest)
15.85%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
1,315.30
1,696.40
-22.47%
Operating Profit (PBDIT) excl Other Income
463.70
520.50
-10.91%
Interest
0.40
0.40
Exceptional Items
7.00
-16.00
143.75%
Consolidate Net Profit
392.70
425.00
-7.60%
Operating Profit Margin (Excl OI)
322.00%
283.20%
3.88%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -22.47% vs 7.93% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -7.60% vs 4.94% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
5,844.50
4,648.20
25.74%
Operating Profit (PBDIT) excl Other Income
1,796.00
1,397.30
28.53%
Interest
7.80
4.20
85.71%
Exceptional Items
14.20
-33.80
142.01%
Consolidate Net Profit
1,557.20
1,151.80
35.20%
Operating Profit Margin (Excl OI)
280.50%
265.40%
1.51%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 25.74% vs 16.97% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 35.20% vs 47.82% in Dec 2023
About Dong-E-E-Jiao Co., Ltd. 
Dong-E-E-Jiao Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






